CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MAZE

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
MAZEPhase 2

MZE829 Phase 2 Est. Readout

MZE829
Sep 2026~STALE
CT.gov
00%
Competitive Landscape

2 competitors in Proteinuric Kidney Disease

View Full Landscape
Drug Information

Target Indication

Proteinuric Kidney Disease

Clinical Trial

NCT06830629

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.